These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30872272)

  • 21. Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
    Sait SN; Claydon MA; Conroy JM; Nowak NJ; Barcos M; Baer MR
    Cancer Genet Cytogenet; 2007 Sep; 177(2):143-6. PubMed ID: 17854671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
    Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLL-SEPT5 Fusion Transcript in Two de novo Acute Myeloid Leukemia Patients With t(11;22)(q23;q11).
    Wang N; Wu X; Sheng G; Ma L; Wen L; Yao H; Chen S
    Ann Lab Med; 2016 Sep; 36(5):501-3. PubMed ID: 27374720
    [No Abstract]   [Full Text] [Related]  

  • 25. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.
    Lee SG; Park TS; Oh SH; Park JC; Yang YJ; Marschalek R; Meyer C; Cho EH; Shin SY
    Acta Haematol; 2011; 126(4):195-8. PubMed ID: 21846973
    [No Abstract]   [Full Text] [Related]  

  • 26. A Case of Acute Myeloid Leukemia with Novel Translocation t(6;11)(p22.2;q23) and Concurrent Insertion ins(11;9)(q23;p21.3p21.3).
    Malinowska I; Sikorska-Fic B; Romiszewska M; Stefaniak A; Pastwińska A; Górska E; Popko K; Meyer C; Marschalek R; Szczepański T
    Adv Exp Med Biol; 2017; 1021():93-98. PubMed ID: 28785923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-101 suppresses the development of
    Gonzales-Aloy E; Connerty P; Salik B; Liu B; Woo AJ; Haber M; Norris MD; Wang J; Wang JY
    Haematologica; 2019 Jul; 104(7):e296-e299. PubMed ID: 30792205
    [No Abstract]   [Full Text] [Related]  

  • 28. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
    Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Shiba N; Ohki K; Hayashi Y; Yamashita Y; Shimada A; Tanaka S; Adachi S
    Haematologica; 2014 Nov; 99(11):e225-7. PubMed ID: 25015941
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of enhancer of mRNA decapping 4 as a novel fusion partner of
    Becker H; Greve G; Kataoka K; Mallm JP; Duque-Afonso J; Ma T; Niemöller C; Pantic M; Duyster J; Cleary ML; Schüler J; Rippe K; Ogawa S; Lübbert M
    Blood Adv; 2019 Mar; 3(5):761-765. PubMed ID: 30833276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of
    Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of pediatric T lymphoblastic leukemia with t(11;17)(q23;q21) involving mixed-lineage leukemia gene rearrangement.
    Kim H; Lee JK; Lee JA; Hong YJ; Hong SI; Jo HS; Chang YH
    Ann Lab Med; 2016 Jan; 36(1):64-6. PubMed ID: 26522762
    [No Abstract]   [Full Text] [Related]  

  • 34. A new cryptic ins(11;1)(q23;q21q31) detected in a t(1;8;11)(q21;p21;q23) in a baby with acute myeloid leukemia FAB AML-M5.
    de Figueiredo AF; Liehr T; Bath S; Binato R; Ventura EM; de Souza MT; de Matos RR; Ribeiro RC; Abdelhay E; Silva ML
    Blood Cells Mol Dis; 2010 Oct; 45(3):197-8. PubMed ID: 20688548
    [No Abstract]   [Full Text] [Related]  

  • 35. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
    Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
    Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
    Duhoux FP; De Wilde S; Ameye G; Bahloula K; Medves S; Légé G; Libouton JM; Demoulin JB; A Poirel H
    Leuk Res; 2011 Mar; 35(3):e18-20. PubMed ID: 20980053
    [No Abstract]   [Full Text] [Related]  

  • 38. The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias.
    Duhoux FP; Ameye G; Libouton JM; Bahloula K; Iossifidis S; Chantrain CF; Demoulin JB; Poirel HA
    Leuk Res; 2011 Sep; 35(9):e171-2. PubMed ID: 21620472
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement.
    Yang JJ; Park TS; Lee ST; Seo JY; Oh SH; Cho EH; Strehl S; Mühlegger N; Dworzak MN; Zuna J; Pospisilova D; Meyer C; Marschalek R; Kim HJ; Kim SH
    Haematologica; 2014 Jan; 99(1):e11-3. PubMed ID: 24425691
    [No Abstract]   [Full Text] [Related]  

  • 40. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.
    von Bergh AR; Beverloo HB; Rombout P; van Wering ER; van Weel MH; Beverstock GC; Kluin PM; Slater RM; Schuuring E
    Genes Chromosomes Cancer; 2002 Sep; 35(1):92-6. PubMed ID: 12203795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.